Skip to content
DataLookout
Menu

NCT06106594

VOLT CE Mark Study

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 6 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 8 versions: 5 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jun 2026 to Jan 2027 Show 4 more changesShow less
    • Eligibility criteria expanded, about 24 words
    • Primary endpoints: details revised at 2 of 3 entries
    • Study completion date: Dec 2026 to Jan 2027
    • Publications: details revised at 2 of 2 entries
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 16 to 11
    v7
  3. Notable Trial status: Active, Not Recruiting to Recruitingv6 Show 6 more changesShow less
    • Primary completion date: Sep 30, 2024 to Jun 2026
    • Enrollment target: 250 to 300
    • Study sites: 11 to 16
    • Study completion date: Sep 2026 to Dec 2026
    • Study description revised
    • Publications: details revised at 2 of 2 entries
  4. Notable Lead sponsor: [Redacted] to Abbott Medical Devicesv5 Show 5 more changesShow less
    • Trial status: Withheld to Active, Not Recruiting
    • Primary completion date: Sep 30, 2024
    • Study completion date: Sep 2026
    • Start date: Oct 24, 2023
    • Study title shortened, about 9 words
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Rate of subjects experiencing a device and/or procedure-related serious adverse event with onset within 7-days of any ablation procedure that uses the Volt PFA System.
Timeframe: 7-days
Acute procedural effectiveness summarized as the rate of pulmonary veins treated with the Volt PFA system that are isolated at the end of the index ablation procedure.
Timeframe: During procedure
Long-term 6-month effectiveness summarized as the rate of freedom from documented AF/AFL/AT episodes of >30 seconds duration after the index ablation procedure through 6 months of follow-up.
Timeframe: 6 months

Arms and interventions

Volt PFA Catheter Sensor Enabled (SE)Experimental

Devices: Pulsed Field Ablation

Sites

11 sites in 7 countries

Australia 4, Belgium 2, Austria 1, Czechia 1, Germany 1, Netherlands 1, Spain 1